‌

US Patent 7976842 Treatment of metastatic breast cancer

Patent 7976842 was granted and assigned to Micromet on July, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Micromet

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79768420

Patent Inventor Names

Robert Saller0

Carsten Reinhardt0

Date of Patent

July 12, 2011

Patent Application Number

121621020

Date Filed

February 9, 2007

Patent Primary Examiner

‌

Sheela J. Huff

Patent abstract

The present invention relates to the use of an anti-EpCAM antibody for the manufacture of a medicament for the treatment of metastatic breast cancer. The present invention further relates to a method of treating metastatic breast cancer comprising administering said anti-EpCAM antibody.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7976842 Treatment of metastatic breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API